Professor Kwun Fong
Professor

Kwun Fong

Email: 

Background

Kwun is a Thoracic and Sleep Physician at The Prince Charles Hospital and University of Queensland Thoracic Research Centre (UQTRC). His research interests are focussed on making and translating research discoveries to improving outcomes and the health of people who are affected by lung disease particularly lung cancer screening/early detection and biomarkers. The UQTRC is also passionate at enabling productive collaborations to maximise research impact and scale with contributions to The Cancer Genome Atlas Project, Pan-Cancer Analysis of Whole Genomes (PCAWG), IASLC Lung Cancer Staging Project and others.

Availability

Professor Kwun Fong is:
Available for supervision

Fields of research

Cardiovascular medicine and haematology Clinical sciences Oncology and carcinogenesis

Research impacts

Lung cancer is the leading cause of cancer mortality in Australia and globally. The prevention, early detection/screening and optimal management of lung cancer will help address the huge burden from lung cancer, enabled by high impact research and addressing stigma and nihilism and the health disparities that exist.

The team at The Prince Charles Hospital and University of Queensland Thoracic Research Centre are passionate, focussed and internationally recognised, leading clinical research in lung cancer in Australia. They are very pleased and privileged to work with patients, families / carers and consumers to make a difference in this awful disease.

Search Professor Kwun Fong’s works on UQ eSpace

445 works between 1986 and 2025
All (445) Journal Article (298) Book Chapter (17) Conference Publication (122) Other Outputs (7) Edited Outputs (1)

341 - 360 of 445 works

2006

Book Chapter

TUMORS, MALIGNANT | Metastases from Lung Cancer

Fong, K. M., Clarke, B. E. and Bowman, R. V. (2006). TUMORS, MALIGNANT | Metastases from Lung Cancer. Encyclopedia of Respiratory Medicine: Volume 1-4. (pp. V4-350-V4-356) Elsevier. doi: 10.1016/B0-12-370879-6/00412-9

TUMORS, MALIGNANT | Metastases from Lung Cancer

2006

Other Outputs

Tumors, Malignant: Bronchogenic Carcinoma

Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, Malignant: Bronchogenic Carcinoma.

Tumors, Malignant: Bronchogenic Carcinoma

2006

Book Chapter

Tumors, malignant: bronchogenic carcinoma

Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, malignant: bronchogenic carcinoma. Encyclopedia of respiratory medicine. (pp. 325-332) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00408-7

Tumors, malignant: bronchogenic carcinoma

2006

Other Outputs

Tumors, Malignant: Overview

Fong, K. M., Bowman, R. V. and Zimmerman, P. V. (2006). Tumors, Malignant: Overview.

Tumors, Malignant: Overview

2006

Conference Publication

Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors

Molenaar, P., Chen, Lu, Meyers, E., Javorsky, G., Burstow, M., Lucas, P., Lolekha, J., Atherton, A., Semmler, A. B., Savarimuthu, S., Fong, K. M., Yang, I. A., Galbraith, A. and Parsonage, W. A. (2006). Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors. The Australian Health and Medical Research Congress, Melbourn, Australia, 26th November - 1st December, 2006. Australia: Australian Govenment NHMRC.

Carvedilol causes a greater increase in heart function in idiopathic dilated cardiomyopathy patients with ARG389-compared to GLY389 Beta1-adrenoceptors

2006

Journal Article

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung

Larsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2006). CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. Carcinogenesis, 27 (3), 525-532. doi: 10.1093/carcin/bgi227

CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung

2006

Journal Article

Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland

Coory, M., Fong, K., Bowman, R. and Hall, L. (2006). Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland. Internal Medicine Journal, 36 (6), 389-392. doi: 10.1111/j.1445-5994.2006.01074.x

Why we need a population-based approach to clinical indicators for cancer: A case study using microscopic confirmation of lung cancer in Queensland

2006

Book Chapter

Tumors, malignant: metastases from lung cancer

Fong, K. M., Clarke, B. E. and Bowman, R. V. (2006). Tumors, malignant: metastases from lung cancer. Encyclopedia of respiratory medicine. (pp. 350-356) London, United Kingdom: Elsevier . doi: 10.1016/B0-12-370879-6/00412-9

Tumors, malignant: metastases from lung cancer

2006

Book Chapter

Tumors, malignant: overview

Fong, K. M., Zimmerman, P. V. and Bowman, R. V. (2006). Tumors, malignant: overview. Encyclopedia of respiratory medicine. (pp. 320-325) London, United Kingdom: Elsevier. doi: 10.1016/B0-12-370879-6/00406-3

Tumors, malignant: overview

2006

Journal Article

Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas

Heller, G., Fong, K. M., Girard, L., Seidl, S., End-Pfutzenreuter, A., Lang, G., Gazdar, A. F., Minna, J. D., Zielinski, C. C. and Zochbauer-Muller, S. (2006). Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Oncogene, 25 (6), 959-968. doi: 10.1038/sj.onc.1209115

Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas

2006

Other Outputs

Bronchogenic Carcinoma

Bowman, R. V., Zimmerman, P. V. and Fong, K. M. (2006). Bronchogenic Carcinoma.

Bronchogenic Carcinoma

2006

Book Chapter

Hematological Malignancies

Wood, P. and Fong, K. M. (2006). Hematological Malignancies. Encyclopedia of Respiratory Medicine. (pp. 339-344) edited by Geoffrey J. Laurent and Steven D. Shapiro. New York: Academic Press (Elsevier). doi: 10.1016/B0-12-370879-6/00410-5

Hematological Malignancies

2006

Other Outputs

Tumors, Malignant: Carcinoma, Lymph Node Involvement

Fong, K. M., Windsor, M., Bowman, R. V. and Duhig, E. (2006). Tumors, Malignant: Carcinoma, Lymph Node Involvement.

Tumors, Malignant: Carcinoma, Lymph Node Involvement

2006

Other Outputs

Tumors, Malignant: Metastases from Lung Cancer

Fong, K. M., Clarke, B. E. and Bowman, R. V. (2006). Tumors, Malignant: Metastases from Lung Cancer.

Tumors, Malignant: Metastases from Lung Cancer

2005

Journal Article

Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation

Zochbauer-Muller, Sabine, Fong, Kwun M., Geradts, Joseph, Xu, Xie, Seidl, Sonja, End-Pfützenreuter, Adelheid, Lang, György, Heller, Gerwin, Zielinski, Christoph C., Gazdar, Adi F. and Minna, John D. (2005). Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene, 24 (41), 6249-6255. doi: 10.1038/sj.onc.1208775

Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation

2005

Journal Article

Cochrane systematic reviews of treatments for lung cancer

Fong, K. M., Yang, I .A., Zimmerman, P. V. and Bowman, R. V. (2005). Cochrane systematic reviews of treatments for lung cancer. Respiratory Medicine, 99 (9), 1071-1078. doi: 10.1016/j.rmed.2005.05.002

Cochrane systematic reviews of treatments for lung cancer

2005

Journal Article

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

Larsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2005). Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes and Control, 16 (5), 579-585. doi: 10.1007/s10552-004-7842-3

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

2005

Journal Article

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

Tothill, R.W., Kowalczyk, A., Rischin, D., Bousioutas, A., Haviv, I., van Laar, R.K., Waring, P.M., Zalcberg, J., Ward, R., Biankin, A.V., Sutherland, R.L., Henshall, S.M., Fong, K., Pollack, J.R., Bowtell, D.D.L. and Holloway, A.J. (2005). An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Research, 65 (10), 4031-4040. doi: 10.1158/0008-5472.CAN-04-3617

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

2005

Journal Article

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

Shigematsu, Hisayuki, Takahashi, Takao, Nomura, Masaharu, Majmudar,Kuntal, Suzuki, Makoto, Lee, Huei, Wistuba, Ignacio I., Fong, Kwun M., Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Minna, John D. and Gazdar, Adi F. (2005). Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Cancer Research, 65 (5), 1642-1646. doi: 10.1158/0008-5472.CAN-04-4235

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas

2005

Journal Article

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

Shigematsu, Hisayuki, Lin, Li, Takahashi, Takao, Nomura, Masaharu, Suzuki, Makoto, Wistuba, Ignacio I., Fong, Kwun M., Lee, Huei, Toyooka, Shinichi, Shimizu, Nobuyoshi, Fujisawa, Takehiko, Feng, Ziding, Roth, Jack A., Herz, Joachim, Minna, John, D. and Gazdar, Adi, F. (2005). Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. Journal of the National Cancer Institute, 97 (5), 339-346. doi: 10.1093/jnci/dji055

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

Current funding

  • 2025 - 2027
    Developing Algorithms for the Characterisation of Environmental and Occupational Foreign Bodies in Lung Tissues
    Prince Charles Hospital Foundation
    Open grant
  • 2024 - 2026
    Volatile organic compounds in exhaled breath to diagnose lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2024 - 2025
    Lung Cancer Screening in Queensland
    Cancer Council Queensland
    Open grant
  • 2023 - 2026
    'Max Up' Trial - Maximising uptake of lung cancer screening and smoking cessation outcomes
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2021 - 2025
    ACRF Lung Cancer Screening CENTRE OF EXCELLENCE (LUSCE)
    Australian Cancer Research Foundation
    Open grant
  • 2021 - 2026
    Lung cancer screening for early detection
    NHMRC MRFF EPCDR - Improving Diagnosis in Cancers with Low Survival Rates
    Open grant
  • 2021 - 2025
    Early lung cancer biomarkers
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2022 - 2024
    Detection of EGRF gene mutation in minimally invasive blood plasma extracellular vesicles for the diagnosis of lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2020 - 2024
    Modelling five-year patterns in cancer incidence, staging and related health services (MRFF THS COR led by Cancer Council NSW)
    University of Sydney
    Open grant
  • 2019 - 2024
    Novel biomarkers for lung cancer
    NHMRC Project Grant
    Open grant
  • 2019 - 2024
    Early diagnosis and treatment of lung cancer
    NHMRC MRFF - Next Generation Clinical Researchers Program
    Open grant
  • 2018 - 2019
    Optima XPN-100 Ultracentrifuge
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2019
    Bringing Modern Genomics to the Management of Lung Cancer in Queensland ( QGHA grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2017 - 2019
    Clinical trial validation of a blood exosome-prognosticator in lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2016 - 2023
    ACRF Centre for Lung Cancer Early Detection
    Australian Cancer Research Foundation
    Open grant
  • 2016 - 2022
    Low Dose Computed Tomography (LDCT) to diagnose Lung Cancer
    NHMRC Project Grant
    Open grant
  • 2014 - 2017
    Optimising screening for lung cancer
    Cancer Bequest Fund
    Open grant
  • 2014 - 2016
    Improving the cancer journey and travel burden for remote patients
    Australian Centre for Health Services Innovation
    Open grant
  • 2014
    Precision Molecular Diagnosis for Lung Cancer
    NHMRC Equipment Grant
    Open grant
  • 2014 - 2016
    Precision molecular lung cancer diagnosis
    Prince Charles Hospital Foundation
    Open grant
  • 2014 - 2016
    Whole genome sequencing for neuroendocrine lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2013 - 2017
    PhD Scholarship in lung cancer - Funded by the Lung Foundation Australia/Neville Bantoft Bequest, with the UQ Thoracic Research Centre
    PhD Scholarship in Lung Cancer funded by the Lung Foundation Australia/Neville Bantoft Bequest
    Open grant
  • 2012 - 2017
    Clinical Academic Fellowship - Thoracic Physician
    Clinical Academic Fellowships
    Open grant
  • 2012 - 2017
    NHMRC Practitioner Fellowship (Level 1)
    NHMRC Practitioner Fellowship
    Open grant
  • 2012 - 2014
    Detection of treatment-responsive lung cancer mutations
    Cancer Council Queensland
    Open grant
  • 2012 - 2013
    Exhaled breath condensate (EBC) from lungs
    Prince Charles Hospital Foundation
    Open grant
  • 2012
    Genomics of never smoking lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2012
    Ion Personal Genome Machine (PGM) equencer for the UQ Thoracic Research Centre
    UQ Major Equipment and Infrastructure
    Open grant
  • 2012 - 2013
    Molecular testing for lung cancer mutations
    Prince Charles Hospital Foundation
    Open grant
  • 2011 - 2012
    Equipment grant for Roche Light Cycler 480 real-time PCR system
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011 - 2016
    Prospective methylation biomarker validation study in lung cancer
    NHMRC Project Grant
    Open grant
  • 2011 - 2012
    The Clinical Utility of High Resolution Melt Analysis in Detecting EGFR Mutations in the Serum of NSCLC Patients
    Pfizer Australia Pty Limited
    Open grant
  • 2010 - 2015
    Centre for Research Excellence in Asbestos Related Diseases (NHMRC CRE administered by The University of Western Australia)
    University of Western Australia
    Open grant
  • 2010 - 2011
    Novel microRNAs in pulmonary neoplasia
    Queensland Health
    Open grant
  • 2009 - 2017
    Low dose CT screening for lung cancer
    Queensland Health Smart Health Research Grant
    Open grant
  • 2009 - 2012
    Genome-wide association study of protective alleles in lung cancer and chronic obstructive pulmonary disease
    Cancer Council Queensland
    Open grant
  • 2008 - 2012
    Genomics of environmental stress and lung damage
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007 - 2013
    Aberrant promoter methylation in lung cancer and smokers (TPCH)
    Queensland Health Smart Health Research Grant
    Open grant
  • 2006 - 2007
    Development of a novel gene therapy vector for multiple modalities of tumour killing
    Queensland Cancer Fund
    Open grant
  • 2006 - 2009
    The role of innate immunity genes in COPD
    NHMRC Project Grant
    Open grant
  • 2005 - 2006
    Innate immunity genes in asthma and allergy
    Asthma Foundation of Queensland
    Open grant
  • 2002 - 2003
    Gene therapy for non small cell lung cancer (NSCLC): the development of a novel strategy for enhancing radio-therapeutic efficacy
    Queensland Cancer Fund
    Open grant

Availability

Professor Kwun Fong is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Precision medicine in the genomic era: emerging technologies for molecular profiling of lung cancer

    Principal Advisor

    Other advisors: Professor Ian Yang

  • Doctor Philosophy

    Randomised pragmatic trial of comprehensive tissue sampling enabled by ultrathin bronchoscopic Radial probe EndoBronchial Ultrasound versus CT-guided TransThoracic needle aspiration/biopsy (REBUTT) for evaluation of peripheral pulmonary lesions.

    Principal Advisor

    Other advisors: Professor Ian Yang

  • Doctor Philosophy

    Effectiveness of Non-invasive Ventilation for the treatment of nocturnal hypoventilation in Myotonic Dystrophy

    Associate Advisor

    Other advisors: Professor Elizabeth Coulson

  • Doctor Philosophy

    Biomarkers of lung cancer

    Associate Advisor

    Other advisors: Professor Ian Yang

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Associate Advisor

    Other advisors: Professor Ian Yang

  • Doctor Philosophy

    Blood biomarkers for lung cancer screening

    Associate Advisor

    Other advisors: Professor Ian Yang, Associate Professor Henry Marshall

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Ian Yang, Associate Professor Henry Marshall

  • Doctor Philosophy

    Combined Compressed sensing and machine learning/deep learning methods for rapid MRI

    Associate Advisor

    Other advisors: Associate Professor Henry Marshall, Dr Hongfu Sun, Professor Feng Liu

Completed supervision

Enquiries

For media enquiries about Professor Kwun Fong's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au